Back to Clinical Trials Overview

Your search for "Gastroenterology" returned 21 results:


A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of GED-0507-34-Levo (GED0507) for treatment of subjects with active ulcerative colitis
Principal Investigator(s): James Marion

A Multicenter, Open-Label Study to Evaluate the Long Term Efficacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease
Principal Investigator(s): James Marion

A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects with Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Principal Investigator(s): Ioannis Oikonomou

A Randomized, Double-Blind, Multicenter Study to Explore The Effect Of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn's Disease
Principal Investigator(s): Bruce Sands

A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects with Crohn’s Disease
Principal Investigator(s): Bruce Sands

A Multicenter Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regiments in Subjects with Moderately Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
Principal Investigator(s): James Marion

Bacterial Transmission In Utero and IBD Risk: The MECONIUM Study
Principal Investigator(s): Inga Peter

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

A multi-center, open-label study of CP-690,550 in subjects with moderate to severe ulcerative colitis (A3921139)
Principal Investigator(s): James Marion

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis
Principal Investigator(s): Chehade, Mirna

Food Protein-Induced Enterocolitis Syndrome - FPIES (ages 6 months-21 years)
Principal Investigator(s): Nowak-Wegrzyn, Anna

Entyvio (vedolizumab) long-term safety study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn's Disease. [MLN-0002_401]
Principal Investigator(s): James Marion

A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of Mongersen (GED-0301) for the treatment of subjects with active Crohn’s disease
Principal Investigator(s): Bruce Sands

A Multicenter Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (LX1606)
Principal Investigator(s): Michelle Kim

A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis
Principal Investigator(s): Bruce Sands

A Phase 3 Prospective, Randomized, Double-Blind, Multi-Center, Phase 2 Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo for Tumor Control in Patients with well Differentiated, Advanced Lung or Thymus Neuroendocrine Tumors (SPINET)
Principal Investigator(s): Michelle Kim

Integrative approaches to managing Irritable Bowel Syndrome (IBS)
Principal Investigator(s): Elizabeth McDonald, MS, RDN, CSSD and Benjamin Kligler, MD, MPH

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection study In Crohn's disease patients (MOBIDIC)
Principal Investigator(s): Jean-Frederic Colombel

A Double-Blind Randomized Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Principal Investigator(s): James Marion

A 24- Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parental Nutrition-Dependent Short Bowel Syndrome CL0600-020
Principal Investigator(s): Iyer, Kishore